;Deal Number;Completed date;Acquiror name;Target name;Target country code;Target US SIC code(s);Deal type
1.;1601389767;25.07.2012;SHIRE STRATEGIC INVESTMENT GROUP;BLUEBIRD BIO INC.;US;2834 / 8731;Minority stake unknown %
2.;1941036170;08.02.2018;SHIRE STRATEGIC INVESTMENT GROUP;RANI THERAPEUTICS INC.;US;2834;Minority stake unknown %
3.;655954;;SHIRE STRATEGIC INVESTMENT GROUP;JERINI AG;DE;2833 / 2834 / 2835 / 2836 / 8731;Capital Increase 9%
4.;1601234586;05.01.2011;SHIRE STRATEGIC INVESTMENT GROUP;DBV TECHNOLOGIES SA;FR;2834 / 8731;Minority stake unknown %
5.;1601349939;15.10.2012;SHIRE STRATEGIC INVESTMENT GROUP;PROMEDIOR INC.;US;2834 / 8731;Minority stake unknown %
6.;1601356646;28.03.2012;SHIRE STRATEGIC INVESTMENT GROUP;PROMETHERA BIOSCIENCES SA/NV;BE;8731;Minority stake unknown %
7.;1601425631;29.11.2012;SHIRE STRATEGIC INVESTMENT GROUP;ARMAGEN TECHNOLOGIES INC.;US;2834 / 8731;Minority stake unknown %